Ampio Pharmaceuticals, Inc. (AMPE)

NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
1.840
-0.030 (-1.60%)
Feb 27, 2024, 4:00 PM EST - Market closed
-1.60%
Market Cap 2.12M
Revenue (ttm) n/a
Net Income (ttm) -8.80M
Shares Out 1.14M
EPS (ttm) -12.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,044
Open 1.880
Previous Close 1.870
Day's Range 1.830 - 1.880
52-Week Range 1.560 - 8.200
Beta 2.08
Analysts n/a
Price Target n/a
Earnings Date Mar 25, 2024

About AMPE

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Michael A. Martino
Employees 5
Stock Exchange NYSEAMERICAN
Ticker Symbol AMPE
Full Company Profile

Financial Performance

Financial Statements

News

Ampio Provides Update on Results from Pre-IND Enabling Studies

ENGLEWOOD, Colo. , Feb. 14, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development of a...

13 days ago - PRNewsWire

Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions

ENGLEWOOD, Colo. , Jan. 11, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development of a...

6 weeks ago - PRNewsWire

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

ENGLEWOOD, Colo. , Oct. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential t...

4 months ago - PRNewsWire

Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

ENGLEWOOD, Colo. , Oct. 5, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential tr...

5 months ago - PRNewsWire

Ampio Pharmaceuticals Announces Reverse Stock Split

ENGLEWOOD, Colo. , Aug. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors has approved a 20-to-1 reverse stock spli...

6 months ago - PRNewsWire

Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

ENGLEWOOD, Colo. , May 26, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors declared a dividend of one one-thousandth ...

9 months ago - PRNewsWire

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

ENGLEWOOD, Colo. , April 18, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin Buchi a...

11 months ago - PRNewsWire

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.

Wilmington, Delaware--(Newsfile Corp. - February 7, 2023) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) on beha...

1 year ago - Newsfile Corp

Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

ENGLEWOOD, Colo. , Dec. 27, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that it has received notification from The NYSE American LLC ("NYSE A...

1 year ago - PRNewsWire

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

ENGLEWOOD, Colo. , Nov. 17, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE) (the "Company") received notification from NYSE American LLC ("NYSE American" or the "Exchan...

1 year ago - PRNewsWire

Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split

Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), announced today that effective November 9, 2022 at 4:01 p.m. Eastern Time, the Company will amend its certificate of incorporation to implem...

1 year ago - PRNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

NEW YORK , Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ampio Pharmaceuticals, Inc.. Shareholders who purchased shares of AMPE during the class perio...

1 year ago - PRNewsWire

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 17, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceuti...

1 year ago - Newsfile Corp

AMPE DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

New York, New York--(Newsfile Corp. - October 17, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (OTC Pink: AMPE) b...

1 year ago - Newsfile Corp

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 17, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("...

1 year ago - Accesswire

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

New York, New York--(Newsfile Corp. - October 16, 2022) - Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities l...

1 year ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

New York, New York--(Newsfile Corp. - October 16, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) ("Ampio" or the "Company"). Such inve...

1 year ago - Newsfile Corp

AMPE DEADLINE TOMORROW: ROSEN, skilled investor counsel, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

NEW YORK , Oct. 16, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (OTC: AMPE) between December 29, 20...

1 year ago - PRNewsWire

Ampio Pharmaceuticals Issues Letter to Stockholders

Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo. , Oct. 14, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the following le...

1 year ago - PRNewsWire

MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceuti...

1 year ago - Newsfile Corp

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK , Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE). To r...

1 year ago - PRNewsWire

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

LOS ANGELES , Oct. 13, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agai...

1 year ago - PRNewsWire

MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 13, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceuti...

1 year ago - Newsfile Corp

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Oct. 13, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities lawsuit. CLASS DEF...

1 year ago - PRNewsWire